ochratoxin a has been researched along with Fetal Death in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dwivedi, P; Sinha, N; Wangikar, PB | 1 |
Dwivedi, P; Sharma, AK; Sinha, N; Wangikar, PB | 1 |
Dwivedi, P; Patil, RD; Sharma, AK | 1 |
Arora, RG; Frölén, H; Nilsson, A | 1 |
Bandyopadhyay, S; Gupta, M; Mazumdar, SK; Paul, B | 1 |
Arora, RG; Frölén, H | 1 |
Hood, RD; Singh, J | 1 |
7 other study(ies) available for ochratoxin a and Fetal Death
Article | Year |
---|---|
Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. I. Maternal toxicity and fetal malformations.
Topics: Abnormalities, Drug-Induced; Aflatoxin B1; Animals; Body Weight; Bone and Bones; Carcinogens; Drug Combinations; Embryonic Development; Female; Fetal Death; Maternal Exposure; Mycotoxins; Ochratoxins; Pregnancy; Rats; Rats, Wistar | 2004 |
Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. II. Histopathological features of teratological anomalies induced in fetuses.
Topics: Abnormalities, Drug-Induced; Aflatoxin B1; Animals; Carcinogens; Drug Combinations; Embryonic Development; Female; Fetal Death; Maternal Exposure; Mycotoxins; Ochratoxins; Pregnancy; Rats; Rats, Wistar | 2004 |
Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Administration, Oral; Animals; Body Weight; Carcinogens; Dose-Response Relationship, Drug; Female; Fetal Death; Fetal Development; Fetal Diseases; Gestational Age; Hydrocephalus; Hydronephrosis; Male; Maternal-Fetal Exchange; Microphthalmos; Ochratoxins; Pregnancy; Rats; Rats, Wistar; Teratogens; Time Factors | 2006 |
Interference of mycotoxins with prenatal development of the mouse. I. Influence of aflatoxin B1, ochratoxin A and zearalenone.
Topics: Abnormalities, Drug-Induced; Aflatoxin B1; Aflatoxins; Animals; Female; Fetal Death; Fetus; Mice; Mice, Inbred CBA; Ochratoxins; Pregnancy; Resorcinols; Zearalenone | 1981 |
Ovarian steroidogenesis and development of fetuses following ochratoxin A treatment in pregnant rats.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Ascorbic Acid; Cholesterol; Corpus Luteum; Female; Fetal Death; Fetal Resorption; Glucosephosphate Dehydrogenase; Ochratoxins; Organ Size; Ovary; Pituitary Gland; Pregnancy; Rats | 1981 |
Interference of mycotoxins with prenatal development of the mouse. II. Ochratoxin A induced teratogenic effects in relation to the dose and stage of gestation.
Topics: Abnormalities, Drug-Induced; Animals; Dose-Response Relationship, Drug; Female; Fetal Death; Fetus; Gestational Age; Mice; Mice, Inbred CBA; Ochratoxins; Pregnancy | 1981 |
Maternal protein deprivation enhances the teratogenicity of ochratoxin A in mice.
Topics: Abnormalities, Drug-Induced; Animals; Embryo Implantation; Feeding Behavior; Female; Fetal Death; Mice; Ochratoxins; Pregnancy; Protein Deficiency | 1985 |